Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Biosimilars Meeting Seeks Input On Product Naming, Foreign Data And Exclusivity

Sep 20 2010

• By The Pink Sheet Daily

Related Content

Biosimilars Pathway Has Blind Spots As FDA And Firms Begin Roadwork

May 03 2010

FDA Won’t Require A Verification Study For Genzyme’s Lumizyme

May 06 2009

FDA's FOBs Implementation Begins With Meetings Both Public And Private

Jul 19 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window